Metabolic syndrome in relation to Barrett’s esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink

March 9, 2016Posted inDrug Safety Studies, Drugs and risk of cancer, Select Publications
Journal: Cancer Epidemiology Authors: Jennifer Drahos, Lin Li, Susan S Jick, Michael B Cook NLM Citation: Drahos J, Li L, Jick SS, Cook MB. Metabolic syndrome in relation to Barrett's esophagus and esophageal…

Does angiotensin-converting enzyme inhibitor and β-blocker use reduce the risk of primary liver cancer? A case-control study using the U.K. Clinical Practice Research Datalink

February 5, 2016Posted inDrug Safety Studies, Drugs and risk of cancer, Select Publications
Journal: Pharmacotherapy Authors: Katrina Wilcox Hagberg, Vikrant V Sahasrabuddhe, Katherine A McGlynn, Susan S Jick NLM Citation: Hagberg KW, Sahasrabuddhe VV, McGlynn KA, Jick SS. Does angiotensin-converting enzyme inhibitor and β-blocker use reduce…

Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink

December 31, 2015Posted inDrug Safety Studies, Drugs and risk of cancer, Safety of other hormone therapies, Select Publications
Journal: International Journal of Cancer Authors: Katherine A McGlynn, Katrina Hagberg, Jie Chen, Megan Braunlin, Barry I Graubard, Neha Suneja, Susan Jick, Vikrant V Sahasrabuddhe NLM Citation: McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI,…